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disease in obese adults: population-based
self-controlled case series study
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Abstract
Background: Hypertension carries a large societal burden. Obesity is known as a risk factor for hypertension.
However, little is known as to whether weight loss interventions reduce the risk of hypertension-related adverse
events, such as acute care use (emergency department [ED] visit and/or unplanned hospitalization). We used
bariatric surgery as an instrument for investigating the effect of large weight reduction on the risk of acute care use
for hypertension-related disease in obese adults with hypertension.
Methods: We performed a self-controlled case series study of obese patients with hypertension who underwent
bariatric surgery using population-based ED and inpatient databases that recorded every bariatric surgery, ED visit, and
hospitalization in three states (California, Florida, and Nebraska) from 2005 to 2011. The primary outcome was acute
care use for hypertension-related disease. We used conditional logistic regression to compare each patient's risk of the
outcome event during sequential 12-month periods, using pre-surgery months 13–24 as the reference period.
Results: We identified 980 obese patients with hypertension who underwent bariatric surgery. The median age was
48 years (interquartile range, 40–56 years), 74% were female, and 55% were non-Hispanic white. During the reference
period, 17.8% (95% confidence interval [CI], 15.4–20.2%) had a primary outcome event. The risk remained unchanged in
the subsequent 12-month pre-surgery period (18.2% [95% CI, 15.7–20.6%]; adjusted odds ratio [aOR] 1.02 [95% CI, 0.83–
1.27]; P = 0.83). In the first 12-month period after bariatric surgery, the risk significantly decreased (10.5% [8.6–12.4%];
aOR 0.58 [95% CI, 0.45–0.74]; P < 0.0001). Similarly, the risk remained significantly reduced in the 13–24 months after
bariatric surgery (12.9% [95% CI, 10.8–15.0%]; aOR 0.71 [95% CI, 0.57–0.90]; P = 0.005). By contrast, there was no
significant reduction in the risk among obese patients who underwent non-bariatric surgery (i.e., cholecystectomy,
hysterectomy, spinal fusion, or mastectomy).
Conclusions: In this population-based study of obese adults with hypertension, we found that the risk of acute care
use for hypertension-related disease decreased by 40% after bariatric surgery. The data provide the best evidence on
the effectiveness of substantial weight loss on hypertension-related morbidities, underscoring the importance of
discussing options for weight reduction when treating obese patients with hypertension.
Keywords: Bariatric surgery, Emergency department visit, Hospitalization, Hypertension, Obesity, Self-controlled case
series study
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Background
Hypertension (HTN) is the leading public health problem,
affecting more than one billion adults worldwide [1]. In
the USA, the prevalence of HTN in adults is approxi-
mately 33% (80.0 million Americans) with estimated direct
and indirect costs of $49 billion in 2012 [2]. Among these
patients, blood pressure is uncontrolled in approximately
half of them, particularly in obese individuals [3, 4]. HTN
accounts for a substantial healthcare utilization, e.g., one
million emergency department (ED) visits and 500,000
hospitalizations annually [2]. In parallel, the USA has also
experienced an obesity epidemic — 35% of men and 40%
of women are obese [5]. Significant weight reduction is
known to decrease blood pressure and sometimes results
in remission of HTN among obese adults [6–10]. Among
various weight management strategies, bariatric surgery is
the most effective method to achieve substantial and sus-
tained weight loss [11]. However, little is known about the
impact of significant weight reduction with bariatric sur-
gery on acute care use (ED visits and/or unplanned hospi-
talizations) for HTN-related disease [12].
In this context, we aimed to determine whether bariat-
ric surgery, as an instrument to achieve large weight re-
duction, reduces the risk of acute care use for HTN-
related disease among obese patients with HTN. To do
this, we used large longitudinal datasets from three di-
verse states. A better understanding of the role of bariat-
ric surgery in the prevention of HTN-associated
morbidities would provide further insight into thera-
peutic strategies for obese patients with HTN.
Methods
Study design and setting
We performed a self-controlled case series study using the
Healthcare Cost and Utilization Project (HCUP) State
Emergency Department Databases (SEDD) and State In-
patient Databases (SID) [13, 14]. The study design was se-
lected because each patient serves as his/her own control;
therefore, a separate control group is not necessary [15].
This study performed intra-person comparisons in the
patients who experienced both the exposure (bariatric sur-
gery) and the outcome (acute care use for HTN-related
disease). Confounding by unmeasured variables was mini-
mized, as all time-invariant covariates (e.g., patient charac-
teristics and genetics) were implicitly controlled [15].
We analyzed the data from HCUP SEDD and SID in
three states (California, Florida, and Nebraska) from
2005 to 2011. The HCUP is the largest longitudinal
hospital care database in the USA and provides all-payer,
encounter-level information [13, 14]. The SEDD records
all ED visits including treat-and-release encounters and
transfers from short-term, acute-care, and nonfederal
hospitals in participating states [13]. The HCUP SID
captures all inpatient discharges from short-term, acute-
care, nonfederal, general, and other specialty hospitals
[14]. Integration of HCUP SEDD and SID enables us to
identify all ED visits regardless of disposition and all hos-
pitalizations regardless of the source of hospitalization in
the three states [13, 14]. We chose these three states
because they are geographically diverse and have unique
patient identifiers that enabled us to perform longitudinal
patient follow-up across the study years within the states.
Details of the study design, databases, and statistical
methods have been published elsewhere [13, 14, 16–19].
The institutional review board of Massachusetts General
Hospital approved this study.
Study population
The following steps were undertaken to identify all obese
adults (aged ≥18 years) who underwent bariatric surgery
and had an acute care use for HTN-related disease in
the three states. First, we identified adults with a diagno-
sis code for obesity who had at least one hospitalization
for bariatric surgery. The International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-
CM) diagnosis codes for obesity were 278.0–278.2,
V77.8, V85.3x, and V85.4 [16–20]. The Current Proced-
ural Terminology codes for bariatric surgery were 43.89,
44.31, 44.38, 44.39, 44.50, 44.68, 44.69, 44.93, 44.95,
44.99, 45.51, and 45.90 [16–20]. We excluded patients
who had diagnostic codes for gastrointestinal cancer
(ICD-9-CM codes 150.0-159.9) [16–19]. To allow for
data collection during the 2-year pre-surgery and post-
surgery periods, we included patients who underwent
bariatric surgery between 1 January 2007 and 31 Decem-
ber 2009. Second, we further identified patients with
HTN, which was defined in the present study as having
at least one acute care use for HTN-related disease dur-
ing the study years, i.e., between 1 January 2005 and 31
December 2011. The ICD-9-CM diagnosis codes for
HTN-related disease were 401 (essential hypertension),
402 (hypertensive heart disease), 403 (hypertensive
chronic kidney disease), 404 (hypertensive heart and
chronic kidney disease), 405 (secondary hypertension),
and 437.2 (hypertensive encephalopathy), as the primary
diagnosis [21, 22]. The exclusion criteria were residents
outside the three states and patients who died during
the hospitalization for bariatric surgery, had an in-
hospital death during the 2-year post-surgery period, or
had multiple bariatric surgeries during the study period.
We also excluded planned hospitalizations to examine
acute care needs in patients with HTN.
Measurements
We used the baseline characteristics recorded during the
index hospitalization for bariatric surgery. We retrieved
demographics data including age, sex, and race/ethnicity
(non-Hispanic white, non-Hispanic black, Hispanic, and
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“other”), primary insurance type (Medicare, Medicaid,
private sources, and “other”), quartiles for estimated me-
dian household income of residents in the patient’s ZIP
code, ICD-9-CM diagnosis, procedures, disposition, sea-
son of surgery, and state.
Statistical analysis
The primary endpoint was a composite of ED visit or
unplanned hospitalization with a primary diagnosis re-
lated to HTN during a 4-year period (i.e., 2 years before
and 2 years after bariatric surgery). We computed ad-
justed odds ratios (aORs) with a conditional logistic re-
gression model using pre-surgery months 13–24 as the
reference period for 1–12 months before surgery, 0–12
months after surgery, and 13–24 months after surgery.
Each patient was matched to his/her own reference
period.
We tested the robustness of our inferences by per-
forming several sensitivity analyses. First, we repeated
the analysis stratified by age group (18–44, 45–54, and
≥55 years) and sex. Second, we modeled the primary
endpoint as a count variable as opposed to a binary out-
come with a negative binomial regression model. Third,
we repeated the primary model in a subgroup of patients
who had at least one acute care use for any reason dur-
ing post-surgery 25–36 months. This sensitivity analysis
addressed the possibility of loss to follow-up (e.g., out-
of-hospital deaths, moving out of the study states). This
subgroup selection method ensured that these patients
were both alive and living within the study states at least
until 2 years after surgery and would have been recorded
in the databases if they had the primary endpoint during
the study period. Fourth, we conducted a sensitivity ana-
lysis using a more restrictive definition of the outcome
event, i.e., only including the ICD-9-CM diagnosis codes
401 and 437.2. Fifth, we performed the self-controlled
case series analysis for four other types of elective sur-
gery: cholecystectomy (Current Procedural Terminology
codes 51.21–51.24 and 51.41–51.59), hysterectomy
(Current Procedural Terminology codes 68.31–68.79
and 68.9), spinal fusion (Current Procedural Termin-
ology codes 81.00–81.66), and mastectomy (Current
Procedural Terminology codes 85.41–85.48) [16, 17].
We performed this analysis to address the possibility
that reductions in the risk of acute care use for HTN-
related disease might be observed with any elective sur-
gery in general (e.g., intensified blood pressure control
during peri-surgical period). We selected these non-
bariatric surgeries because they have a large sample size,
similar characteristics (i.e., common elective surgery),
and no biological plausibility to affect weight or the risk
of acute care use for HTN-related disease. Lastly, to de-
lineate the differential effects of individual types of bar-
iatric surgery on the risk of acute care use for HTN-
related disease, we performed separate self-controlled
case series analyses for the two most common types of
bariatric surgery: gastric bypass (Current Procedural
Terminology codes 44.31, 44.38, and 44.39) and gastric
banding (Current Procedural Terminology codes 44.68
and 44.95) [23]. All analyses were performed at a two-
sided significance level of 0.05, and all confidence inter-
vals (CIs) were reported as two-sided values with a con-
fidence level of 95%. Statistical analyses were performed
with SAS version 9.4 (SAS Institute, Cary, NC, USA).
Results
We identified a total of 1022 obese adults who under-
went bariatric surgery between 1 January 2007 and 31
December 2009 and also had at least one ED visit or
hospitalization with a primary diagnosis related to HTN
between 1 January 2005 and 31 December 2011. From
this population, we excluded 18 patients who had an in-
hospital death within 2 years after bariatric surgery and
26 patients who underwent multiple bariatric surgeries
(two patients had both). We included the remaining 980
patients in the primary analysis. Table 1 describes the
baseline characteristics at the time of bariatric surgery.
The median age was 48 years (interquartile range, 40–56
years), 74% were female, and 55% were non-Hispanic
white.
Table 2 summarizes the risk of acute care use for
HTN-related disease in the pre- and post-bariatric sur-
gery periods. During the reference period (i.e., 13–24
months prior to bariatric surgery), we observed at least
one acute care use for HTN-related disease in 17.8%
(95% CI 15.4–20.2%) of the study population. The risk
did not change in the following 12-month pre-surgery
period (18.2%, 95% CI 15.7–20.6%), corresponding to an
aOR of 1.02 (95% CI 0.83–1.27; P = 0.83). By contrast,
we observed a significant decline in the risk after bariat-
ric surgery. Within 12 months after bariatric surgery,
10.5% (95% CI 8.6–12.4%) experienced an acute care use
for HTN-related disease (aOR 0.58, 95% CI 0.45–0.74; P
< 0.0001). The risk remained significantly reduced dur-
ing the subsequent period of 13–24 months post-surgery
(12.9%, 95% CI 10.8–15.0%), corresponding to an aOR
of 0.71 (95% CI 0.57–0.90; P = 0.005; Fig. 1).
In the stratification analysis by age group with a
limited statistical power, a similar risk reduction was ob-
served in the 18–44 and 45–54 year age groups
(Additional file 1). The sensitivity analysis stratified by
sex showed that women had a similar reduction in the
risk over the 2-year post-surgery period, while men had
a significant reduction only in the first 12 months after
bariatric surgery (Additional file 2). The sensitivity ana-
lysis modeling the outcome as a count variable repli-
cated the findings of the main analysis (Additional file
3). Likewise, the subgroup analysis of patients who had
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any acute care use during 25–36 months after bariatric
surgery (n = 325) showed, even with a limited statistical
power, a similar pattern with a larger effect size (Table 3).
The sensitivity analysis using a more restrictive defin-
ition of HTN-related disease demonstrated consistent
results (Additional file 4). By contrast, in the separate
self-controlled case series analyses with obese patients
with HTN who underwent cholecystectomy (n = 378),
hysterectomy (n = 112), spinal fusion (n = 61), or mastec-
tomy (n = 30), the risk of the primary outcome did not
decrease after non-bariatric surgery (Table 4). The sensi-
tivity analysis according to the type of bariatric surgery
showed that the point estimate of the odds ratio was
lower after gastric bypass compared to gastric banding
(Additional file 5).
Discussion
Principal findings
By using population-based data of patients with HTN
who underwent bariatric surgery in the three diverse
states, we found that the risk of acute care use for HTN-
related disease decreased by 40% after bariatric surgery.
The observed large decline in the risk remained signifi-
cant for at least 2 years after surgery. In contrast, other
non-bariatric surgeries were not associated with a
reduced risk of acute care use for HTN-related disease,
addressing the possibility that the observed decrease in
the risk might be attributable to intensified blood pres-
sure control during the peri-surgical period.
Results in context
Several studies have reported that large weight reduction
by surgical interventions lowers blood pressure and
sometimes leads to remission of HTN [6–10]. However,
the inferences from these studies on HTN-related
healthcare utilization are potentially limited by the lack
of assessment of acute care utilization (e.g., ED visit or
hospitalization) related to HTN. By contrast, in the
present study, both the population and the outcome are
unique, because all patients had at least one ED visit or
hospitalization for HTN-related disease, and the risk of
such healthcare utilization was assessed. This study adds
to the body of knowledge by demonstrating the effect-
iveness of substantial weight reduction (bariatric surgery
as an instrument) on the risk of hospital-based acute
care use for HTN-related disease among obese patients
with HTN.
Physiological studies in humans have indicated that a
substantial weight loss can reverse some of the links be-
tween obesity and HTN-related morbidities. For in-
stance, weight loss intervention has been reported to
improve blood pressure control with a dose–response
relationship [24, 25]. Bariatric surgery has been known
to favorably affect endothelial function, systemic inflam-
mation, and oxidative stress [24–28]. Moreover, the
present study demonstrated that bariatric surgery was
associated with a substantially and persistently lower risk
of acute care use for HTN-related disease. Additionally,
gastric bypass surgery, which is known to result in a lar-
ger weight loss (~60% excess weight loss) than gastric
banding (~35% excess weight loss) [29], may achieve a
larger risk reduction compared to gastric banding. Our
data, along with prior evidence, collectively indicate that
substantial weight loss may reverse the link between
obesity and HTN-related morbidities.
Advantages of the study design
The self-controlled case series design augments the in-
ternal validity, because it eliminates inter-personal varia-
tions and enables a precise assessment of impact of the
Table 1 Baseline characteristics of patients with hypertension
who underwent bariatric surgery
Characteristics Number (n) = 980
Age (years), median (IQR) 48 (40–56)
Female sex 718 (73.6)
Race/ethnicitya
Non-Hispanic white 512 (54.8)
Non-Hispanic black 254 (27.2)
Hispanic 142 (15.2)
Other 26 (2.8)
Primary insurance
Medicare 240 (24.5)
Medicaid 108 (11.0)
Private 560 (57.2)
Other 71 (7.3)
Quartiles for median household income of patient's ZIP code
1 (lowest) 301 (31.1)
2 265 (27.4)
3 235 (24.3)
4 (highest) 167 (17.3)
Season of bariatric surgery
January–March 204 (20.8)
April–June 234 (23.9)
July–September 281 (28.7)
October–December 261 (26.6)
State
California 600 (61.2)
Florida 368 (37.6)
Nebraska 12 (1.2)
Data were expressed as numbers (percentages), unless otherwise indicated.
IQR interquartile range
aAnalyzed for 934 (95.3%) patients with race/ethnicity data. Race/ethnicity
data were not available in Nebraska
Shimada et al. BMC Medicine  (2017) 15:161 Page 4 of 9
Table 2 Number of patients and risk of acute care use for hypertension-related disease
Time interval and outcome Number of patients Risk, % (95% CI) aOR (95% CI)a P value
(n = 980)
13–24 months before bariatric surgery
ED visit or hospitalizationb 174 17.8 (15.4–20.2) Reference –
ED visitc 130 13.3 (11.1–15.4) Reference –
Hospitalizationd 44 4.5 (3.2–5.8) Reference –
1–12 months before bariatric surgery
ED visit or hospitalizationb 178 18.2 (15.7–20.6) 1.02 (0.83–1.27) 0.83
ED visitc 130 13.3 (11.1–15.4) 1.00 (0.78–1.28) 0.99
Hospitalizationd 50 5.1 (3.7–6.5) 1.14 (0.76–1.73) 0.53
0–12 months after bariatric surgery
ED visit or hospitalizationb 103 10.5 (8.6–12.4) 0.58 (0.45–0.74) <0.0001
ED visitc 91 9.3 (7.5–11.1) 0.69 (0.53–0.91) 0.008
Hospitalizationd 14 1.4 (0.7–2.2) 0.31 (0.17–0.57) <0.0001
13–24 months after bariatric surgery
ED visit or hospitalizationb 126 12.9 (10.8–15.0) 0.71 (0.57–0.90) 0.005
ED visitc 100 10.2 (8.3–12.1) 0.76 (0.58–0.99) 0.04
Hospitalizationd 30 3.1 (2.0–4.1) 0.68 (0.42–1.08) 0.10
CI confidence interval, aOR adjusted odds ratio, ED emergency department
aAdjusted odds ratios are for each 12-month period versus the reference period (i.e., 13–24 months before the index bariatric surgery), as calculated with
conditional logistic regression
bAt least one acute care use (ED visit or unplanned hospitalization) for HTN-related disease
cAt least one ED visit for HTN-related disease, not resulting in hospitalization
dAt least one unplanned hospitalization for HTN-related disease
Fig. 1 Risk of acute care use for hypertension-related disease before and after bariatric surgery in a 6-month interval. Shown is the proportion of patients
with an acute care use (ED visit and/or unplanned hospitalization) related to HTN with the 95% CIs for the 2 years before and after bariatric surgery in
6-month intervals. The periods were centered on the date of bariatric surgery of each patient. CI confidence interval, ED emergency department,
HTN hypertension
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exposure (i.e., bariatric surgery) [15]. In addition, in con-
trast to the traditional case–control or other cohort
study designs, confounding by time-invariant variables
(both measured and unmeasured) is addressed, as each
subject functions as a control for her/himself [15]. Be-
cause of these advantages, the self-controlled case series
study design has been successfully used to demonstrate
the associations between weight reduction and morbidity
in other disease conditions (e.g., congestive heart failure,
asthma, and stable angina pectoris) [16–18]. The present
study meets the requirements of the self-controlled case
series design, because the exposure is transient and
discrete and the outcome is an acute event [15].
With regard to the external validity, it has been reported
that subjects participating in randomized controlled trials
(RCTs) may be highly selected or behave differently com-
pared to the general populations in the real-world setting
[30, 31]. For instance, most of the previously published
RCTs on bariatric surgery enrolled <10% of the screened
patients [32, 33]. By contrast, the patients analyzed in the
Table 3 Number of patients and risk of acute care use for hypertension-related disease, limiting to patients with any healthcare
utilization during 25–36 months after bariatric surgery
Number of patients Risk, % (95% CI)a aOR (95% CI)b P value
Time interval (n = 325)
13–24 months before bariatric surgery 59 18.2 (13.9–22.4) Reference –
1–12 months before bariatric surgery 52 16.0 (12.0–20.0) 0.87 (0.59–1.29) 0.49
0–12 months after bariatric surgery 29 8.9 (5.8–12.0) 0.47 (0.30–0.74) 0.001
13–24 months after bariatric surgery 41 12.6 (9.0–16.2) 0.68 (0.45–1.02) 0.06
CI confidence interval, aOR adjusted odds ratio
aAt least one acute care use (ED visit or unplanned hospitalization) for HTN-related disease
bAdjusted odds ratios are for each 12-month period versus the reference period (i.e., 13–24 months before the index bariatric surgery), as calculated with
conditional logistic regression
Table 4 Number of patients and risk of acute care use for hypertension-related disease among obese patients with hypertension
who underwent non-bariatric surgery
Time interval and surgery Number of patients Risk, % (95% CI)a aOR (95% CI)b P value
Cholecystectomy (n = 378)
13–24 months before surgery 64 16.9 (13.1–20.7) Reference –
1–12 months before surgery 129 34.1 (29.3–38.9) 2.13 (1.56–2.91) <0.0001
0–12 months after surgery 135 35.7 (30.9–40.6) 2.24 (1.65–3.06) <0.0001
13–24 months after surgery 67 17.7 (13.9–21.6) 1.05 (0.74–1.49) 0.79
Hysterectomy (n = 112)
13–24 months before surgery 20 17.9 (10.7–25.1) Reference –
1–12 months before surgery 42 37.5 (28.4–46.6) 2.26 (1.29–3.95) 0.004
0–12 months after surgery 34 30.4 (21.7–39.0) 1.78 (1.002–3.18) 0.049
13–24 months after surgery 21 18.8 (11.4–26.1) 1.05 (0.56–1.99) 0.87
Spinal fusion (n = 61)
13–24 months before surgery 11 18.0 (8.1–28.0) Reference –
1–12 months before surgery 20 32.8 (20.7–44.9) 1.92 (0.89–4.14) 0.10
0–12 months after surgery 17 27.9 (16.3–39.4) 1.60 (0.73–3.53) 0.24
13–24 months after surgery 11 18.0 (8.1–28.0) 1.00 (0.42–2.37) 0.99
Mastectomy (n = 30)
13–24 months before surgery 5 16.7 (25.1–30.8) Reference –
1–12 months before surgery 11 36.7 (18.4–55.0) 2.34 (0.78–6.98) 0.13
0–12 months after surgery 9 30.0 (12.6–47.4) 1.87 (0.61–5.78) 0.28
13–24 months after surgery 5 16.7 (25.1–30.8) 1.00 (0.28–3.55) 0.99
CI confidence interval, aOR adjusted odds ratio
aAt least one acute care use (ED visit or unplanned hospitalization) for HTN-related disease
bAdjusted odds ratios are for each 12-month period versus the reference period (i.e., 13–24 months before surgery), as calculated with conditional
logistic regression
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present study have diverse racial/ethnic, socioeconomic,
and geographic characteristics with the use of large
population-based databases that capture all ED visits and
hospitalizations in the studied states. This diversity in the
study population strengthens the external validity of our
inferences.
Possible differential effects according to age group and sex
In the sensitivity analysis stratifying patients by age
group, we observed similar risk reduction of acute care
use for HTN-related disease after bariatric surgery in the
younger populations. This finding is mirrored by a prior
retrospective cohort study in patients who underwent
bariatric surgery. That study reported that improvement
in HTN control was observed in a significantly greater
proportion of patients <60 years of age compared to pa-
tients ≥60 years of age [34]. In addition, although we ob-
served that the direction and effect size of bariatric
surgery on the risk of acute care use for HTN-related
disease during the first year after bariatric surgery was
similar across female and male patients, the effect per-
sisted longer in female patients. The potential reasons
for this discrepancy are likely multifactorial, such as dif-
ferences in health behaviors [35, 36], access to healthcare
[37–40], pre-existent cardiovascular comorbidities [41–
43], or any combination of these factors [44]. For ex-
ample, older and male patients might have had more
established arterial atherosclerosis which would be less
reversible with weight loss [45, 46]. Our observations
suggest that weight reduction achieved by bariatric sur-
gery may not be sufficient to prevent HTN-associated
morbidities among older or male patients with HTN.
The results of these stratified analyses underscore the
importance of identifying underlying mechanisms that
account for the differential effects of bariatric surgery
and developing targeted strategies for the patient popu-
lations in whom bariatric surgery may be less effective.
Accuracy of case, exposure, and outcome identification
Although the HCUP databases have been widely used in
the literature, and the quality has been extensively tested
[16–19, 47], misclassification is possible as with any
studies using administrative data. With regard to obesity,
the specificity of the ICD-9-CM codes for obesity was
reported to be 99.4% [48]. While the HCUP databases
did not include data on body mass index, patients with-
out obesity have therefore been excluded from our study
[48]. Regarding the exposure, the method of identifying
patients who underwent bariatric surgery has been used
in several studies [16–20]. Moreover, it is well docu-
mented in the literature that bariatric surgery leads to
substantial weight loss [49]. For example, prompt weight
loss was observed within a few months after bariatric
surgery and persisted for 12 to 18 months, with a mean
weight loss of 35% [49]. These data support the idea that
bariatric surgery can be used as an effective method to
achieve significant weight reduction. With respect to the
outcome, the set of ICD-9-CM codes has been used in
previously published studies, and this combination has
been shown to have a specificity of 95% and a positive
predictive value of 97% for identifying HTN-related ED
visits [21, 22]. Thus, our outcome identification strategy
has effectively excluded acute care use for conditions
other than HTN-related disease.
Potential limitations
Our study has several potential limitations. First, the
probability of exposure may have been affected by a pre-
vious outcome event — for instance, patients who had
an acute care use for HTN-related disease during the
pre-operative period would not have undergone bariatric
surgery while blood pressure was poorly controlled.
However, this would have decreased the risk in the pre-
surgery period and hence biased the inferences toward
the null [15]. Second, we determined the risk of acute
care use for HTN-related disease by ED visits or un-
planned hospitalizations [12]. Therefore, one might
argue that there might have been a compensatory in-
crease in less acute forms of healthcare utilization for
HTN (e.g., walk-in clinic, urgent care, and other ambula-
tory care visits). However, we also observed a significant
reduction in the risk of hospitalizations, arguing against
this possibility. Third, patients might have been lost to
follow-up after bariatric surgery, thereby downwardly
biasing our estimates. However, the sensitivity analysis
limiting to patients who were confirmed to be alive and
living within the study states for at least 2 years after
surgery showed consistent findings. Fourth, the HCUP
database did not include several potentially useful pa-
rameters such as information on diet, exercise, medica-
tion use, and patient education. Therefore, one might
surmise that the observed reduction in the risk may be a
result of intensified HTN management during the peri-
surgical period and may not be unique to bariatric sur-
gery. However, it would be difficult to postulate that the
risk reduction was fully attributable to intensified antihy-
pertensive treatment for the following reasons: (1) a
number of prior studies have reported that the majority
of patients were able to either discontinue or decrease
the number of antihypertensive medications after bariat-
ric surgery [2–6], (2) no reduction in the risk was ob-
served among obese adults with HTN who underwent
elective non-bariatric surgery, and (3) there was no
signal of risk reduction immediately prior to bariatric
surgery when the medical regimen for HTN was likely
optimized. It is possible that medication compliance
might have improved after bariatric surgery. Finally, the
inferences from our study may not be generalizable to
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other countries with optimal access to and resources in
the primary care setting.
Conclusions
This self-controlled case series study using large population-
based datasets from three US states demonstrated that bar-
iatric surgery is associated with a significant reduction in the
risk of acute care use for HTN-related disease among obese
adults with HTN. However, a large proportion of obese
adults with HTN would choose not to undergo bariatric sur-
gery for various reasons, such as an absence of indications,
lack of insurance coverage, and peri-surgical risk. Our data
also underscore the importance of developing safe and ef-
fective noninvasive weight loss strategies for obese patients
with HTN to relieve the large societal burden of acute care
use for HTN-related disease. Such effort should progress in
concert with public health interventions to primarily prevent
obesity and HTN to begin with.
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